Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Living Cell Technologies ( (AU:1AI) ) has issued an announcement.
Algorae Pharmaceuticals Limited has applied for quotation of 1,663 new fully paid ordinary shares on the ASX, with an issue date of 19 December 2025. The small-scale share issuance, arising from the exercise or conversion of existing instruments, marginally increases the company’s quoted capital and reflects ongoing capital management activities without significantly altering its overall market position or capital structure.
More about Living Cell Technologies
Algorae Pharmaceuticals Limited is an Australian-listed pharmaceutical company, trading on the ASX under the code 1AI. The company operates in the life sciences sector, focusing on the development and commercialisation of pharmaceutical products and related technologies.
YTD Price Performance: 50.0%
Average Trading Volume: 3,240,501
Technical Sentiment Signal: Buy
Current Market Cap: A$25.33M
For a thorough assessment of 1AI stock, go to TipRanks’ Stock Analysis page.